Cargando…
Protective Activity of Erythropoyetine in the Cognition of Patients with Parkinson’s Disease
Introduction: Treatment strategies in Parkinson’s disease (PD) can improve a patient’s quality of life but cannot stop the progression of PD. We are looking for different alternatives that modify the natural course of the disease and recent research has demonstrated the neuroprotective properties of...
Autores principales: | Pedroso, Ivonne, Garcia, Marité, Casabona, Enrique, Morales, Lilia, Bringas, Maria Luisa, Pérez, Leslie, Rodríguez, Teresita, Sosa, Ileana, Ricardo, Yordanka, Padrón, Arnoldo, Amaro, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5981245/ https://www.ncbi.nlm.nih.gov/pubmed/29862060 http://dx.doi.org/10.3390/bs8050051 |
Ejemplares similares
-
Analysis of Sleep Macrostructure in Patients Diagnosed with Parkinson’s Disease
por: González-Naranjo, Justa Elizabeth, et al.
Publicado: (2019) -
EEG-Derived Functional Connectivity Patterns Associated with Mild Cognitive Impairment in Parkinson’s Disease
por: Peláez Suárez, Alejandro Armando, et al.
Publicado: (2021) -
The Effect of Neuroepo on Cognition in Parkinson’s Disease Patients Is Mediated by Electroencephalogram Source Activity
por: Bringas Vega, Maria L., et al.
Publicado: (2022) -
Semantic and Phonemic Verbal Fluency in Parkinson’s Disease: Influence of Clinical and Demographic Variables
por: Obeso, Ignacio, et al.
Publicado: (2012) -
Flanker Task-Elicited Event-Related Potential Sources Reflect Human Recombinant Erythropoietin Differential Effects on Parkinson's Patients
por: Bringas Vega, Maria L., et al.
Publicado: (2020)